ly 353381 has been researched along with Bone Fractures in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amewou-Atisso, M; Christiansen, C; Cox, D; Cummings, SR; McClung, M; Miller, P; Mitlak, B; Powles, T; Reginster, JY; Stock, J; Zanchetta, J | 1 |
| Chines, AA; Komm, BS | 1 |
| Agnusdei, D; Amewou-Atisso, M; Cox, DA; Cummings, SR; Diem, SJ; Dowsett, SA; Fabian, CJ; Muram, D; Neven, P; Powles, TJ; Wickerham, DL | 1 |
1 review(s) available for ly 353381 and Bone Fractures
| Article | Year |
|---|---|
An update on selective estrogen receptor modulators for the prevention and treatment of osteoporosis.
Topics: Bone Density Conservation Agents; Breast; Endometrium; Female; Fractures, Bone; Humans; Indoles; Osteoporosis, Postmenopausal; Piperidines; Pyrrolidines; Selective Estrogen Receptor Modulators; Tamoxifen; Tetrahydronaphthalenes; Thiophenes | 2012 |
2 trial(s) available for ly 353381 and Bone Fractures
| Article | Year |
|---|---|
Arzoxifene for prevention of fractures and invasive breast cancer in postmenopausal women.
Topics: Aged; Aged, 80 and over; Bone Resorption; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Placebos; Postmenopause; Selective Estrogen Receptor Modulators; Thiophenes | 2011 |
Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene.
Topics: Aged; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Ductal, Breast; Double-Blind Method; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis, Postmenopausal; Piperidines; Postmenopause; Risk Factors; Thiophenes | 2012 |